|

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

RECRUITINGSponsored by Tempus AI
Actively Recruiting
SponsorTempus AI
Started2024-06-26
Est. completion2029-06-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations31 sites
View on ClinicalTrials.gov →

NCT06207032

Summary

This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

1. ≥18 years of age
2. Willing to participate in the research
3. Able to provide informed consent
4. Must be diagnosed with cancer

Exclusion Criteria:

1\. Not willing or able to have additional blood samples collected

Conditions1

Cancer

Locations31 sites

Alabama Oncology
Birmingham, Alabama, 35233
Amanda JosephAmanda.Joseph@AlabamaOncology.com
PIH Health Whittier Hospital & PIH Health Physicians
Whittier, California, 90605
Kristine Bradbury562-698-0811kristine.bradbury@pihhealth.org
Eastern CT and Hematology and Oncology Associates
Norwich, Connecticut, 06360
James Champlin860-886-8362jchamplin@echoct.com
Cancer Specialists of North Florida
Jacksonville, Florida, 32256
Erin Shephard904-538-4488Erin.Shepard@CSNF.us
Morehouse
Atlanta, Georgia, 30310
Justyn Dawsonjustyn.dawson@msm.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.